DCN and neoplasm: DCN, as the small leucine-rich proteoglycan (SLRP) family class I member, always serves as the ligand of receptor tyrosine kinases to restrict tumor proliferation (Santra et al., 2000) or modulate tumor angiogenesis signals (Järveläinen et al., 2015).